Novel GBCAs Elucirem, Vueway Now Available for Use in Contrast Enhanced MRI
Gadopiclenol only requires half of the gadolinium dose of conventional nonspecific GBCAs.
Diagnosis & Disease Information
FDA Approves Xenoview for Evaluating Lung Ventilation
The approval was based on data from 2 clinical trials that compared Xenoview MRI to xenon Xe 133 scintigraphy in adults with pulmonary disorders.
Gadopiclenol, a New Macrocyclic Gadolinium-Based Contrast Agent, Gets FDA Approval
Gadopiclenol carries a Boxed Warning associated with an increased risk of nephrogenic systemic fibrosis among patients with impaired elimination of the drugs.
Iomeron Allowed for Temporary Importation to Address Contrast Media Shortage
To address the ongoing COVID-19 related iodinated contrast media product shortage, Iomeron will be temporarily available in the US starting at the end of August 2022.
Fresenius Kabi Launches Generic Iodinated Contrast Media Agent to Alleviate Shortage
Due to COVID-19 related supply-chain disruptions, Iodixanol and other contrast media agents have been in shortage nationwide.
Lymphoseek Approval Expanded to Pediatric Patients
The approval was based on data from a phase 2 trial that assessed Lymphoseek in pediatric patients with melanoma, RMS, or other solid tumors.
- Loading...
Loading...
Next post in News
Loading... 
Loading...